Inventiva
Founded 2012 · 126 employees on LinkedIn · 8 known investors
Find your way into Inventiva
Inventiva is a clinical-stage biopharmaceutical company developing drug candidates, with a focus on liver and other diseases. The page presents investor relations content including financial results and corporate governance updates.
Investors · 8
European Investment Bank✓ verifiedLuxembourg
Andera PartnersParis
Claret Capital PartnersLondon
New Enterprise Associates (NEA)Menlo Park · $200K – $40M
Samsara BioCapitalPalo Alto
Sofinnova PartnersParis · $540K – $27M
Biotechnology Value FundreportedSan Francisco
Novo HoldingsreportedCopenhagen · $1.1M – $54M
Competitors · 1
by search overlapCompanies competing with Inventiva for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Frequently asked questions
- What does Inventiva do?
- Inventiva is a clinical-stage biopharmaceutical company developing drug candidates, with a focus on liver and other diseases. The page presents investor relations content including financial results and corporate governance updates.
- Who are Inventiva's investors?
- Inventiva's investors include European Investment Bank, Andera Partners, Claret Capital Partners, New Enterprise Associates (NEA), Samsara BioCapital, Sofinnova Partners, Biotechnology Value Fund, Novo Holdings.




